ICON plc Acquires MolecularMD Corporation
February 21, 2019
ICON plc acquired MolecularMD Corporation, a molecular diagnostic specialty laboratory, to expand ICON's molecular diagnostic testing capabilities—including next-generation sequencing and immunohistochemistry—and strengthen support for oncology drug–diagnostic co-development. The acquisition integrates MolecularMD's central laboratory services and client base into ICON's global laboratory network to support precision medicine programs across clinical development phases.
- Buyers
- ICON plc
- Targets
- MolecularMD Corporation
- Industry
- Healthcare Services
- Location
- Oregon, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
LabGenomics USA Acquires Integrated Molecular Diagnostics (IMD) CLIA Labs
October 25, 2024
Healthcare Services
LabGenomics USA acquired Integrated Molecular Diagnostics (IMD) CLIA labs, expanding its U.S. footprint to four CLIA-certified laboratories and strengthening its molecular and oncology diagnostic capabilities. The deal broadens LabGenomics' geographic reach across the U.S. coasts and positions the company to launch new laboratory-developed tests (LDTs) and expand reimbursable services.
-
MLM Medical Labs Acquires MD Biosciences, Inc.
October 27, 2020
Healthcare Services
MLM Medical Labs, a Great Point Partners portfolio company, has acquired MD Biosciences, Inc., an Oakdale, Minnesota-based provider of preclinical, translational and clinical-phase contract research services. The deal expands MLM's U.S. footprint and adds immunohistochemistry, preclinical research and histopathology capabilities to its global laboratory platform as part of an integration with recent U.S. additions such as CirQuest Labs.
-
ACT Genomics Acquires MC Diagnostics
August 10, 2021
Medical Devices
Taiwan-based precision medicine company ACT Genomics has acquired North Wales–headquartered molecular diagnostics specialist MC Diagnostics (MCD). The deal gives ACT Genomics access to MCD’s ALDAS microarray platform and point-of-care testing capabilities, supporting ACT’s expansion into Europe and development of additional genechip-based diagnostic products.
-
Medica Group PLC Acquires RadMD
March 22, 2021
Healthcare Services
Medica Group PLC has acquired RadMD, a Philadelphia-based Imaging Contract Research Organisation (iCRO). The acquisition gives Medica entry into the clinical trials market and diversifies its customer base and geographic operations, combining Medica’s teleradiology capabilities with RadMD’s imaging expertise and reader network.
-
Discovery Life Sciences Acquires QualTek Molecular Laboratories
May 5, 2019
Healthcare Services
Discovery Life Sciences (based in Huntsville, Alabama) has acquired QualTek Molecular Laboratories, a provider of CAP/CLIA-accredited and GLP-capable immunohistochemistry (IHC) laboratories in California and Pennsylvania. The acquisition expands Discovery's histopathology and IHC assay development capabilities and integrates QualTek's services with Discovery's biospecimen, sequencing, flow cytometry and multiomic annotation offerings to accelerate biomarker validation and drug/diagnostic development.
-
JMD Properties, Inc. Acquires Stella Diagnostics
September 2, 2020
Biotechnology
JMD Properties, Inc. announced the acquisition of Stella Diagnostics, LLC via a preferred stock transaction and will change its corporate name to Stella Diagnostics, Inc. The deal positions the public company to pivot into the molecular diagnostics / biotech sector to commercialize Stella’s oncology-focused assays for esophageal disease.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.